212 related articles for article (PubMed ID: 17482247)
1. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
2. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
3. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
[TBL] [Abstract][Full Text] [Related]
4. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
Gehrke BJ; Harrod SB; Cass WA; Bardo MT
Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
[TBL] [Abstract][Full Text] [Related]
5. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
[TBL] [Abstract][Full Text] [Related]
6. Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Neurochem Res; 2006 Nov; 31(11):1359-69. PubMed ID: 17053968
[TBL] [Abstract][Full Text] [Related]
7. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
[TBL] [Abstract][Full Text] [Related]
8. Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Takemura M
Behav Pharmacol; 2014 Apr; 25(2):158-65. PubMed ID: 24557322
[TBL] [Abstract][Full Text] [Related]
9. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
10. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
11. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
[TBL] [Abstract][Full Text] [Related]
12. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
13. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
[TBL] [Abstract][Full Text] [Related]
14. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
15. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats.
Narita M; Akai H; Kita T; Nagumo Y; Narita M; Sunagawa N; Hara C; Hasebe K; Nagase H; Suzuki T
Neuroscience; 2005; 132(3):553-60. PubMed ID: 15837117
[TBL] [Abstract][Full Text] [Related]
16. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
Riddle JL; Rokosik SL; Napier TC
Behav Brain Res; 2012 Jul; 233(1):15-23. PubMed ID: 22727039
[TBL] [Abstract][Full Text] [Related]
17. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.
Baracz SJ; Rourke PI; Pardey MC; Hunt GE; McGregor IS; Cornish JL
Behav Brain Res; 2012 Mar; 228(1):185-93. PubMed ID: 22155611
[TBL] [Abstract][Full Text] [Related]
19. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
Fujita Y; Kunitachi S; Iyo M; Hashimoto K
Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872
[TBL] [Abstract][Full Text] [Related]
20. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
Kitanaka N; Kitanaka J; Watabe K; Takemura M
Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
